title: Insulin treatment in children and adolescents with diabetes.
authors.affiliation: Department of Pediatrics, Oslo University Hospital, Ullevål, Norway. haba@uus.no
authors.forename: Hans-Jacob
authors.initials: HJ
authors.lastname: Bangstad
authors.forename: Thomas
authors.initials: T
authors.lastname: Danne
authors.forename: Larry
authors.initials: L
authors.lastname: Deeb
authors.forename: Przemyslawa
authors.initials: P
authors.lastname: Jarosz-Chobot
authors.forename: Tatsuhiko
authors.initials: T
authors.lastname: Urakami
authors.forename: Ragnar
authors.initials: R
authors.lastname: Hanas
mesh_terms: D000042:Absorption; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D061267:Insulin Aspart; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D061267:Insulin Aspart